Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Estate of Bladder Cancer Victim Files Actos Lawsuit

Filed June 21st, 2012 Laurie

Parker Waichman LLP has filed a lawsuit on behalf of the estate of a Kentucky man who allegedly died of bladder cancer because he used the diabetes drug Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co. as defendants.

The plaintiff-decedent took the drug between 2010 and 2011. According to the complaint, he allegedly developed bladder cancer from his use of Actos, and passed away last November. The suit alleges that Actos caused severe mental and physical pain and suffering leading up to his death. It also alleges economic loss due to medical expenses and living related expenses as a result of a new lifestyle.

The lawsuit says the defendants either knew or should have known that Actos is associated with bladder cancer, but failed to adequately warn the public. The complaint also states that the plaintiff-decendent would not have taken Actos if he had known about its risks.

In September 2010, the FDA publicly acknowledged the potential risk between Actos and bladder cancer in a Safety Communication. The agency released an updated Safety Communication last June stating that the risk of bladder cancer increased after taking Actos for more than a year, and that the risk increased with the time and dosage.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!